New Study Identifies Distinct Entity in Pachychoroid Disease: Pachyvitelliform Maculopathy

• RPE Dysfunction and Atrophy: Retinal pigment epithelium disruption was present in 64.71% of eyes with PVM at baseline, and 41.18% developed macular atrophy by the end of the follow-up period.

The researchers suggest a possible pathogenesis of RPE dysfunction in PVM, which may be related to the thick choroid in affected eyes. This could lead to the accumulation of undigested photoreceptor outer segments and the formation of AVL. Clinicians should be aware of this common cause of vitelliform lesions and the poor visual prognosis due to the high risk of atrophy development.

Pachyvitelliform maculopathy is an important addition to the spectrum of pachychoroid disease, and understanding its distinct features can aid in accurate diagnosis and appropriate management. As the study highlights the association between choroidal thickness and RPE dysfunction, further research may shed light on potential treatment strategies to address this visual impairment effectively.

Early detection and intervention are crucial in managing PVM, and ophthalmologists should remain vigilant in recognizing the signs and symptoms of this condition to provide timely care and optimize patient outcomes. Future studies may explore potential therapeutic approaches to address RPE dysfunction and prevent or slow down the development of macular atrophy in PVM patients.

Reference:

Hilely, A., Au, A., Lee, W. K., Fogel Levin, M., Zur, D., Romero-Morales, V., Santina, A., Lee, J. S., Loewenstein, A., & Sarraf, D. (2023). Pachyvitelliform maculopathy: an optical coherence tomography analysis of a novel entity. The British Journal of Ophthalmology. https://doi.org/10.1136/bjo-2022-322553